thumbnail image

UE LifeSciences

  • Home
  • iBreastExam
  • cervAIcal
  • About Us 
    • Journey
    • Team
  • …  
    • Home
    • iBreastExam
    • cervAIcal
    • About Us 
      • Journey
      • Team
Latest News!

UE LifeSciences

  • Home
  • iBreastExam
  • cervAIcal
  • About Us 
    • Journey
    • Team
  • …  
    • Home
    • iBreastExam
    • cervAIcal
    • About Us 
      • Journey
      • Team
Latest News!
  • Home
  • iBreastExam
  • cervAIcal
  • About Us
    • Journey
    • Team
  • Search
    • Our Journey

      { Pennsylvania Dept of Health Grant Award, Philadelphia }

    • Journey in Moments

      Inspiring. Surprising. Joyful.

      TED Talk with Shahrukh Khan
      Meeting Bill Gates
    • Journey in Time

      Transforming Dreams into Action

      2018 - 2021

      Starting to Scale

      • 8 Additional Regulatory Approvals & Distribution Partnerships (Mexico, Egypt, Southeast Asia, South Asia)
      • Broad Scale Validation with International KOLs (ASCO 2020, ASBS 2020, SABCS 2019, JCPCR 2018)

      • $400k in Grant & Awards from Pfizer Foundation, Bayer Cares Foundation, etc

      • New Patent Application Filed (July 2020)

      • iBreastExam 2nd Gen Sensor Invented, Developed New FDA/CE Mark & Made Production Ready

      • Business Collaboration with Pfizer (April 2021)

      • 400,000 women reached, $3M+ in cumulative revenue

      2015 - 2017

      Ramping Up

      • iBreastExam receives US FDA clearance, CE Mark
      • Manufacturing facility established in India (ISO 13485 and WHO:GMP certifications)
      • StartHealth Grant Award, Unitus Seed Fund ($80K).
      • $4.2M raised from Dr. Ranjan Pai, Mrs. Kiran Mazumdar Shaw  & Unitus Seed Fund
      • GE Healthcare obtains distribution rights for 25 Emerging Markets
      • Over 20,000 women served in various pilot programs across public and private healthcare partners, 
      • $1.5M in cumulative revenue + $400k in Grant Awards

      2009 - 2014

      Laying the Foundation

      • Founders kick-off operations with angel investment of $150,000 in Jan 2009
      • First Product  NoTouch BreastScan developed, two studies completed, FDA clearance, CE Mark
      • Sales in 5 countries, 5,000 women examined , $1.5M in cumulative revenues 
      • Pennsylvania Department of Health's CURE Grant Award for $878,000
      • Licensing agreement with Drexel University for new sensor technology commercialization 
      • iBreastExam commercial prototype developed by a multidisciplinary team of scientists, engineers and clinicians as a hand-held point-of-care device for use by community health workers
      • University City Science Center Digital Health Accelerator Award for $50,000
    • Founders' Note

      Mihir Shah

      "When you are looking at a disease like cancer from a family member's perspective, it takes a little while to learn and truly digest the fact this is a global scale challenge, one that's not being addressed and not going away anytime soon! Once the realization set in that it's not going to be an easy problem to solve is when I told myself that we have a real ballgame at hand."

      Matthew Campisi

      "Being touched personally by breast cancer certainly provides the passion and motivation to work hard for a solution. But when you realize the global breadth of the problem, you realize it's about so much more than yourself. It is an honor and a privilege to have this opportunity to be part of something with such global impact."

    • Leadership Team

      Advisors & Partners

      Our support systems

      Mihir Shah

      Founder & CEO

      Matt Campisi

      Co-Founder & CTO

      We are 68+ strong team

      Across 3 continents!

    Home

    Journey

    Team

    News

    Contact Us

    iBreastExam

    cervAIcal

    UE LifeSciences Inc. Copyright © 2021 | Terms & Conditions

      Invest
      News
      Call
      Email
    All Posts
    ×
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More